Ginkgo Bioworks Holdings, Inc.

DNANYSEUSD
7.54 USD
0.76 (11.21%)AT CLOSE (11:59 AM EDT)
7.43
0.12 (1.53%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
7.43
0.12 (1.53%)
🟢Market: OPEN

DNA is currently priced at $7.43. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. DNA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Aug 25, 2026.

Open?$6.94
High?$7.63
Low?$6.86
Prev. Close?$6.78
Volume?1.7M
Avg. Volume?1.1M
VWAP?$7.44
Rel. Volume?1.56x
Bid / Ask
Bid?$7.40 × 100
Ask?$7.57 × 500
Spread?$0.17
Midpoint?$7.49
Valuation & Ratios
Market Cap?456.6M
Shares Out?55.4M
Float?42.4M
Float %?76.6%
P/E Ratio?N/A
P/B Ratio?1.09
EPS?-$4.32
Dividend?0.00%
Ex-Dividend?N/A
RelatedTWST
News
Profile
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Employees
485
Market Cap
456.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-04-19
Address
27 DRYDOCK AVENUE
BOSTON, MA 02210
Phone: (877) 442-5362
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
55
Short Sent.?
55
Piotroski F-Score?1/9Weak
Altman Z-Score?-8.96Distress
Confidence?61%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?13.19%High
Short Interest?5.6M
Days to Cover?4.3
Free Float42.4M
Avg Daily Volume1.3M
Settlement Date2026-08-14
Financial Health
Current Ratio?4.57Strong
Quick Ratio?4.57Strong
Cash Ratio?1.16Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
97
1.09CHEAP
P/S?
Peers
100
S&P
37
4.08FAIR
P/FCF?
N/A
EV/EBITDA?
S&P
97
-1.5CHEAP
EV/Sales?
Peers
100
S&P
56
3.33FAIR
Returns & Efficiency
ROE?
S&P
3
-69.2%WEAK
ROA?
S&P
3
-29.4%WEAK
Cash Flow & Enterprise
FCF?$-174800000
Enterprise Value?$372.0M
Fundamentals ratios updated end of day